Abstract
In the UK, there has been a rapid increase in the reclassification of prescription only medicines (POMs) to pharmacy only (P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.
Original language | English |
---|---|
Pages (from-to) | 129-134 |
Number of pages | 6 |
Journal | Pharmacy World & Science |
Volume | 25 |
Issue number | 4 |
DOIs | |
Publication status | Published - Aug 2003 |
Keywords
- Antifungal Agents
- Candidiasis, Vulvovaginal
- Clinical Trials as Topic
- Community Pharmacy Services
- Evidence-Based Medicine
- Female
- Great Britain
- Humans
- Nonprescription Drugs
- Quality Assurance, Health Care
- Self Medication